Kidney Research and Clinical Practice

Metabolic risks in living kidney donors in South Korea: Eunjeong Kang, Jina Park, Hyo Jeong Kim et al.; Kidney Res Clin Pract. 2021;40(4):645-659. Published online October 12, 2021; DOI: https://doi.org/10.23876/j.krcp.20.271
Web of Science 3 Cited By 4; Full text PubReader ePub PDF Supplementary Material

Hyperuricemia is a risk factor for the progression to end-stage renal disease in minimal change disease: Su Hyun Song, Tae Ryom Oh, Hong Sang Choi et al.; Kidney Res Clin Pract. 2021;40(3):411-418. Published online September 9, 2021; DOI: https://doi.org/10.23876/j.krcp.20.220
Web of Science 5 Cited By 4; Full text PubReader ePub PDF

Physicians’ perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey: Ran-hui Cha, Su Hyun Kim, Eun Hui Bae et al.; Kidney Res Clin Pract. 2019;38(3):373-381. Published online September 30, 2019; DOI: https://doi.org/10.23876/j.krcp.19.007
Web of Science 4 Cited By 4; Full text PubReader PDF Supplementary Material

Use of dapagliflozin in patients with advanced diabetic kidney disease: Hyun Sun Park, Youn Joo Jung, Dong-Young Lee, Kyoung Hyoub Moon, Beom Kim, Hae Won Kim; Kidney Res Clin Pract. 2018;37(3):292-297. Published online September 30, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.3.292
Web of Science 5 Cited By 5; Full text PubReader PDF

Relationship between serum uric acid and mortality among hemodialysis patients: Retrospective analysis of Korean end-stage renal disease registry data: Chang Seong Kim, Dong-Chan Jin, Young Cheol Yun, Eun Hui Bae, Seong Kwon Ma, Soo Wan Kim; Kidney Res Clin Pract. 2017;36(4):368-376. Published online December 31, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.4.368
Web of Science 38 Cited By 40; Full text PubReader PDF Supplementary Material

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis: Sollip Kim, Hyun-Jung Kim, Hyeong-Sik Ahn et al.; Kidney Res Clin Pract. 2017;36(3):274-281. Published online September 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.3.274
Web of Science 40 Cited By 37; Full text PubReader PDF Supplementary Material

Hyperuricemia as a marker for progression of immunoglobulin A nephropathy: Su-Ji Kim, Jung-Hoon Kim, Hyo-Wook Gil, Jong-Oh Yang, Eun-Young Lee, Sae-Yong Hong; Kidney Res Clin Pract. 2012;31(3):186-191. Published online July 20, 2012; DOI: https://doi.org/10.1016/j.krcp.2012.07.003
Cited By 4; Full text PubReader PDF

14,636	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,557	C4d Puzzle in ABO-incompatible kidney transplantation
7,981	How should we treat acute kidney injury caused by renal congestion?
12,797	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
34,867	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Search